Holen Sie sich die Stockscreener-App
1.89
1.05%
-0.02
Schlusskurs vom Vortag:
$1.91
Offen:
$1.92
24-Stunden-Volumen:
85,748
Relative Volume:
0.16
Marktkapitalisierung:
$4.48M
Einnahmen:
$574.20K
Nettoeinkommen (Verlust:
$-11.52M
KGV:
-0.0412
EPS:
-45.8332
Netto-Cashflow:
$-6.92M
1W Leistung:
-0.53%
1M Leistung:
-7.35%
6M Leistung:
-33.22%
1J Leistung:
+8.62%
1-Tages-Spanne:
$1.84
$1.96
1-Wochen-Bereich:
$1.84
$2.1299
52-Wochen-Spanne:
$0.5079
$5.89
Aethlon Medical Inc Stock (AEMD) Company Profile
Firmenname
Aethlon Medical Inc
Sektor
Branche
Telefon
619-941-0360
Adresse
11555 SORRENTO VALLEY ROAD, SUITE 203, SAN DIEGO, CA
Compare AEMD vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AEMD
Aethlon Medical Inc
|
1.89 | 4.48M | 574.20K | -11.52M | -6.92M | -45.83 |
ABT
Abbott Laboratories
|
88.41 | 153.99B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.80 | 118.00B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
79.34 | 101.86B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
45.29 | 67.32B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.36 | 50.30B | 6.30B | 1.07B | 1.09B | 1.8406 |
Aethlon Medical Inc Stock (AEMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-07 | Fortgesetzt | H.C. Wainwright | Neutral |
Aethlon Medical Inc Aktie (AEMD) Neueste Nachrichten
Aethlon Medical Inc (AEMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Aethlon Medical Inc (AEMD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Aethlon Medical Inc (AEMD) Institutional Confidence - TradingKey
Aethlon Medical Inc (AEMD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Aethlon Medical advances Hemopurifier study as final trial cohort nears completion - Proactive financial news
Aethlon Medical Inc (AEMD) Q4 2026 Earnings Call Highlights: Str - GuruFocus
AEMD Q1 2026 Earnings: Narrower-than-Expected Loss Drives Positive Stock ReactionCash Flow Report - newsline.com
AEMD Q1 2026 Earnings: Slight EPS Beat Amid Pre-Revenue Status, Stock Gains Over 6%Revenue Estimate Trend - lwvtexas.org
AEMD Q1 2026 Earnings: Narrower-than-Expected Loss Lifts SharesEarnings Volatility Report - newsline.com
Aethlon Medical (AEMD) Reports Q4 2026 Progress in Hemopurifier Trials - GuruFocus
Aethlon Medical Q4 2026 Earnings Call Transcript - MarketBeat
Aethlon outlines cohort 3 expansion to 3–6 patients as Hemopurifier oncology trial advances - MSN
Aethlon Medical FY2026 Earnings: Hemopurifier Advances and Financial OverviewNews and Statistics - IndexBox
Aethlon (AEMD) Q4 2026 Earnings Transcript - The Globe and Mail
Aethlon Medical Reports Fiscal 2026 Results, Clinical Progress - TipRanks
Earnings call transcript: Aethlon Medical Q4 2026 reveals financial strides By Investing.com - Investing.com South Africa
Earnings call transcript: Aethlon Medical Q4 2026 reveals financial strides - Investing.com
AEMD: Operating loss narrowed and clinical milestones achieved as Hemopurifier trials advance - TradingView
Aethlon Medical (AEMD) flags going-concern risk while advancing Hemopurifier trials - Stock Titan
AEMD: Operating expenses fell 21.9% and net loss narrowed as clinical and preclinical programs advanced - TradingView
Aethlon Medical Inc FY 2026: Revenue ($7.17M), Net income ($7.15M), EPS ($10.61) — 10-K Summary - TradingView
Q4 2026 Aethlon Medical Inc Earnings Call Transcript - GuruFocus
Aethlon Medical | 8-K: Current report - Moomoo
Net loss narrows at Aethlon Medical (Nasdaq: AEMD) as trials advance - Stock Titan
Aethlon Medical Announces Fiscal Year End March 31, 2026 Financial Results and Corporate Update - Yahoo Finance
Earnings Scheduled For June 10, 2026 - Benzinga
AEMD: Operating expenses fell 21.9% and net loss improved to $7.2M as clinical programs advanced - TradingView
AEMD Q4'25 Earnings: EPS estimate is (2.17) USD - TradingView
Aethlon Medical, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
AEMD Q1 2026 Earnings: Narrower-Than-Expected Loss Amid Continued Pre-Revenue StageEarnings Stability Report - newsline.com
Aethlon Medical (AEMD.US) will release its earnings report after market close on June 10. - Moomoo
AEMD News | AETHLON MEDICAL INC (NASDAQ:AEMD) - ChartMill
Aethlon Medical Updates At-The-Market Equity Offering Capacity - TipRanks
Aethlon Medical raises $542,716 capacity under amended ATM prospectus - TradingView
Aethlon Medical (NASDAQ: AEMD) raises ATM capacity to $542,716 - Stock Titan
AEMD (NASDAQ: AEMD) amends ATM prospectus; $542.7K remaining capacity - Stock Titan
Aethlon Medical (AEMD) to Release Fiscal Year-End Results and Ho - GuruFocus
Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 10, 2026 - Yahoo Finance Singapore
Hear Aethlon explain its 2026 results: investor Q&A call June 10 - Stock Titan
Aethlon Medical Company Profile & Introduction - Moomoo
Aethlon Medical (AEMD) Plunges 24.83% as Stock Breaks Below Key Support LevelsImpulse Wave - The Legal Advocate
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
AEMD Q1 2026 Earnings: EPS Beats Estimates by 0.75% Amid Revenue Absence, Stock Declines 15.96%EPS Growth Rate - newsline.com
AEMD Stock Pops As Hemopurifier Draws Ebola Outbreak Focus - StocksToTrade
Medical Tech Stock Aethlon Medical (Nasdaq: AEMD) Jumps Amid Escalating Ebola Crisis - Investorideas.com
AEMD Stock Jumps As Hemopurifier Spotlight Returns On Ebola - timothysykes.com
Why Semtech Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket - Benzinga
AEMD Q1 2026 Earnings: Narrower-than-Expected Loss Boosts Investor SentimentCore Business Growth - newsline.com
AEMD Q1 2026 Earnings: Slightly Better Than Expected Loss Amid No RevenueCEO Earnings Statement - newsline.com
Finanzdaten der Aethlon Medical Inc-Aktie (AEMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.93%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):